Anastasios Fokas
Optometrist · Astoria, NYNPI 1275533432
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $107 of the $127 with a category attached, or 84.7%. 5 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 41.3% of the total. 2025 is the largest year on record at $69, 4.0 times the $17 reported in 2019. That places this record below the midpoint for optometrist clinicians in NY, where the typical reported total is $538.
Across 7 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$52
- Oyster Point Pharma, Inc.$21
- Carl Zeiss Meditec AG$19
- Bausch & Lomb Americas Inc.$17
- Tarsus Pharmaceuticals, Inc.$17
What the payments were for
- Food & beverage$10785%
- Gifts$1915%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 3 | $52 |
| Oyster Point Pharma, Inc. | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| Tarsus Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$127 in reported general payments places this provider in the 20th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 16 | $6,662 |
| Loteprednol Etabonate | 26 | $4,325 |
| Latanoprost | 486 | $3,439 |
| Brimonidine Tartrate | 33 | $3,153 |
| Timolol Maleate | 192 | $3,020 |
| Travoprost | 13 | $2,171 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 127 | $2,099 |
| Fluorometholone | 39 | $2,032 |
| Prednisolone Acetate | 50 | $1,507 |
| Azelastine Hcl | 108 | $1,419 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 127 | $1,133 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Astoria
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.